Hara Levy, MD, MMSc

Titles
Pediatric pulmonologist, Children's Hospital of Wisconsin; assistant professor, Pediatrics, The Medical College of Wisconsin.

Division
Pulmonary Medicine

Research interests
Genetic diseases/genomics, respiratory diseases, asthma, cystic fibrosis, fetal concerns/prematurity diseases.

Study interests
Genetic modifiers for cystic fibrosis, correlation between genotype and varied phenotypic expressions in CF patients, CF newborn screening.

Education
Medical degree, Medical College of Wisconsin, Milwaukee, 1991; residency, Medical College of Wisconsin, Milwaukee, 1996; Pediatric Cardiology fellowship, Children's Hospital, Philadelphia, 1997; Pediatric Scientist Development Training program fellow, Genetics, Harvard Medical School, Boston, 2000; Clinical fellow, Pulmonary Medicine, Pediatric Pulmonology, Children's Hospital, Boston. MA, 2001.

Certifications
Diplomate, National Board of Medical Examiners, 1992-present; diplomate, Americal Board of Internal Medicine-Internal Medicine, 2007; diplomate, American Board of Pediatrics, 2000-present; member, American College of Physicians - American Society of Internal Medicine, 2001-present; fellow, American Academy of Pediatrics, 2005-present; American Board of Pediatrics, Sub-Board certification, Pediatric Pulmonology, 2010-present. 

Honors
Pediatric Scientist Development Training Fellowship Award, Harvard Medical School, Boston, 2000; Clinical Fellowship Award, Cystic Fibrosis Foundation, Children's Hospital, Boston, 2001; Glaser Foundation Research Fellowship, Children's Hospital, Boston, 2003; Pediatric-Extramural, National Institutes of Health Loan Repayment program, Children's Hospital, Boston, 2007; American Thoracic Society Unrestricted Research Funding Award, Children's Hospital, Boston, 2007.

Representative publications

• Ly NP, Ruiz-Perez B, Onderdonk A, Tzianabos AO, Litonjua AA, Liang C, Laskey D, Delaney ML, DuBois AM, Levy H, Gold DR, Ryan LM, Weiss ST, Celedon JC. Mode of Delivery and Cord Blood Cytokines: A Birth Cohort Study. Clinical and Molecular Allergy. 2006; 4-13. PMID: 17002791.
• Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, Celedon JC, Pier GB, Weiss ST. Inflammatory Markers of Lung Disease in Adult Patients with Cystic Fibrosis. Pediatric Pulmonology. 2007; 42(3):256-62. PMID: 17245735.
• Levy H, Kalish LA, Cannon CL, Garcia KC, Gerard C, Goldmann D, Pier GB, Weiss ST, Colin AA. Predictors of Mucoid Pseudomonas Colonization in Cystic Fibrosis Patients. Pediatric Pulmonology. 2008; 43(5)463-71. PMID: 18361452.
• Levy H, Murphy AJ, Zou F, Gerard C, Klanderman BJ, Schuemann B, Lazarus R, Garcia KC, Celedon JC, Drumm M, Dahmer MK, Quasney MW, Schneck K, Reske M, Knowles MR, Pier GB, Lange C, Weiss ST. IL1-β Polymorphisms Modulate Cystic Fibrosis Lung Disease. Pediatric Pulmonology. 2009; 44 (6):580-593. PMID: 19431193.  
• Jadin SA, Wu GS, Zhang Z, Shoff SM, Tippets BM, Farrell PM, Miller T, Rock MJ, Levy H and Lai, HJ. Growth and Pulmonary Outcomes during the First Two Years of Life of Breastfed and Formula-fed Infants Diagnosed with Cystic Fibrosis through the Wisconsin Routine Newborn Screening Program. The American Journal of Clinical Nutrition.  May; 93(5):1038-47. Epub 2011 Mar 23. PMID: 21430114.
• Rock MJ, Levy H, Zaleski C, Farrell PM. Factors Accounting for a Missed Diagnosis of Cystic Fibrosis after Newborn Screening. Pediatric Pulmonology. 2011: in press.  
• Schneck K, Stachiw-Hietpas D, Nugent M, Laxova A, Rock MJ, Farrell PM, Simpson P, Levy H. Phenotype and Genotype Characteristics of Patients with Cystic Fibrosis Metabolic Syndrome. Pediatric Pulmoniology. 2011.  Submitted.   
• Levy H, Wang X, Kaldunski M, Jia S, Gorski J and Hessner MJ. Plasma Induced Transcriptional Signatures in Cryopreserved Reported Cells as a Predictive Disease Specific Biomarker. Nature Medicine. 2011. Submitting.           

Grants

Peer Review:

• Integration of Genomics with Genetics-Molecular Phenotypes for CF Lung Disease, National Institutes of Health/Office of the Director, principal investigator.
• Family Gene Polymorphisms and Susceptibility to p. aeruginosa in CF Patients, National Institutes of Health/National Heart, Lung and Blood Institute, principal investigator.
• Pulmonary Benefits of Cystic Fibrosis Neonatal Screening, National Institutes of Health/National Heart, Lung and Blood Institute, subcontract principal investigator (PI: Philip M. Farrell, PhD).

Non-Peer Review

• A Molecular signature Identifies as IL1RN Response in Cystic Fibrosis (CF) Lung Disease, Genentech, principal investigator.
• Serum Induced Transcriptional Signature in T1DM and its Relationship to CFDM, Juvenile Diabetes Research Foundation, co-investigator (PI: Martin Hessner, PhD).

Pending
Peer Review

• Malnutrition and Lung Disease in Cystic Fibrosis, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease, co-principal investigator (PI: HJ Lai, PhD).
• Efficacy of Tailored Family-Centered Genetic Counseling for Cystuic Fibrosis, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease, co-principal investigator, (PI: Audrey Tluczek, PhD).

Contact
Children's Hospital of Wisconsin
PO Box 26509
Milwaukee, WI 53226
Phone: (414) 955-2379
Fax: (414) 266-6734
E-mail: hlevy@mcw.edu